APA (7th ed.) Citation

Walker, J. L., Brady, M. F., Wenzel, L., Fleming, G. F., Huang, H. Q., DiSilvestro, P. A., . . . Mannel, R. S. (2019). Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Journal of clinical oncology, 37(16), 1380. https://doi.org/10.1200/JCO.18.01568

Chicago Style (17th ed.) Citation

Walker, Joan L., et al. "Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study." Journal of Clinical Oncology 37, no. 16 (2019): 1380. https://doi.org/10.1200/JCO.18.01568.

MLA (9th ed.) Citation

Walker, Joan L., et al. "Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study." Journal of Clinical Oncology, vol. 37, no. 16, 2019, p. 1380, https://doi.org/10.1200/JCO.18.01568.